GLAZER CAPITAL, LLC - 08 Aug 2025 SCHEDULE 13G Report for Y-mAbs Therapeutics, Inc. Common Stock, $0.0001 par value (YMAB)

Filing Manager: GLAZER CAPITAL, LLC
Reporting Manager: Glazer Capital, LLC
Security: Y-mAbs Therapeutics, Inc. Common Stock, $0.0001 par value
Symbol: YMAB
Shares outstanding: 45,457,192 shares
Disclosed Ownership: 2,654,700 shares
Ownership: 5.8%
Form type: SCHEDULE 13G
Filing time: 15 Aug 2025, 16:28:04 UTC
Date of event: 08 Aug 2025
Next filing: 13 Nov 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Glazer Capital, LLC	5.8%	2,654,700	0	2,654,700	Paul J. Glazer	Paul J. Glazer, Managing Member
Paul J. Glazer	5.8%	2,654,700	0	2,654,700	Paul J. Glazer	Paul J. Glazer